
WASHINGTON — PhRMA, the eminent lobbying group for the pharmaceutical industry, spent more than $27.5 million on its lobbying activities in 2018 — the most the group has ever spent on lobbying in a single year.
The tally, as detailed in lobbying filings posted online on Tuesday, far outstrips the group’s previous record-setting spend, when it dropped a little more than $25 million in 2009, as Congress was deep in the debate over the Affordable Care Act. It spent just shy of that figure again in 2017.
Trump administration escalates its efforts to bring drug prices down
That’s hilarious! There is none in there having any genuine interest in doing so. Other then, possibly hoping to gain consensus with voters. But mainly, pretending to change something, while keeping things the way they are to please their lobbyists donors and the real entities they care to benefit, pharma companies